Another analysis by Lamberti et al. [64] examined clinical, pathological, and genomic data associated with high (≥50%), low (1–49%) and negative (<1%) PD-L1 expression in 909 non-squamous NSCLC samples. Here, CD274 is linked to non-small cell lung carcinoma.